|
I |
GUANGZHOU YOU-HAO HOSPITAL ONCOLOGY CENTRE 廣州友好醫院腫瘤综合治療中心
|
I |
Home About Us Treated cases Treatments offered About PET/CT FAQ Contact Us |
Treated Cases. |
Case Study 1: Liver Cancer
Name: Mr. Deng
Physical Education teacher in secondary school.
Age: 36
Diagnosis upon Admission:
Liver cancer. Medical History:
Admitted to hospital due to weight loss, lack of appetite for
about 3 months, bloatedness in liver region. Examination upon admission:
AFP 90.81ng/L.
CT scan and ultrasound: lesion in right lobe of liver.
Treatment:
2006 October 12 localised chemotherapy and arterial embolism (Transcutaneous Arterial Chemoembolism) 2006 October 30 performed
interstitial radiotherapy for the liver cancer.
Condition after treatment: Living and working normally.
Case Study 2: Liver Cancer
Name: Mr. Lu
Sports trainer in Beijing
Age: 62
Diagnosis
upon admission:- Liver cancer.
Medical History:
2006 December 14: Physical examination, B ultrasound and CT scan indicated lesion in liver, tested positive for hepatitis C antibodies
2006 Dec 26 and 2007 Feb 1 underwent transcutaneous arterial chemoembolism.
Indication from B-ultrasound: Right side of liver and gallbladder uneven echo 3.3*4.5,
laboratory
tests: ALT:2.2, AST:60.6, ALP:102.2, AFP:16.35, CEA:0.52. Treatment: 2007 Mar 31 performed I¹²5particle implantation using 50 particles . Discharged from hospital 5 days later.
Case 3: Liver Cancer
Name: Mr. Jian from Gaoxiong City, Taiwan
Age: 54
Diagnosis upon Admission: Liver cancer
Medical History: 2006 October B Ultrasound and CT discovered a lesion of diameter size of 1.2 cm.
2006 December had a needle biopsy of the liver tumour, liver cancer according to pathological diagnosis.
2007 February CT reexamination: tumour size about 3.2cm.
Condition upon admission: Heart, lungs and stomach normal. Liver-spleen subcostal no metastasis. Lab results: Glu: 8.41mmol/l, ALT: 82u/l, AST:54.5 u/l, ALP: 118.5u/l,
HbsAg: +ve, HbeAb: +ve, HbcAb: +ve. 2007 April 4 Under CT guidance and local anaesthesia, thirty I¹²5 particles were implanted together with injection of 5-FU, DDP, Lipiodol ultra-fluid, absorbable gelatin sponge. After the operation administered anti-inflammation, haemostatic and support therapies. One course of biotherapy.
Condition after treatment:
Living well. |
|
|
|